• 10th Dermatology Drug Development Summit

    The Colonnade Hotel 120 Huntington Ave, Boston, MA, United States

    10th Dermatology Drug Development Summit – Discovering, Developing & Commercializing Next-Generation Inflammatory Skin Disease Therapeutics - November 3-5, 2026 | Boston, MA The 10th Dermatology Drug Development Summit returns in […]

  • 2nd Model-Informed Drug Development Summit 2026

    Wyndham Boston Beacon Hill 5 Blossom St, Boston, MA, United States

    As model-informed drug development (MIDD) becomes increasingly central to modern drug development strategy, organizations are under growing pressure to leverage quantitative approaches that accelerate timelines, reduce risk, and improve regulatory […]

  • Novel CNS Biomarkers Summit Europe

    The Hilton London Olympia 380 Kensington High St, Kensington, London, United Kingdom

    Introducing Europe’s first CNS Biomarker Forum. The Novel CNS Biomarkers Summit Europe is the only European meeting dedicated exclusively to advancing fluid, imaging, and digital biomarkers for CNS drug development. Bringing […]

  • 8th CNS Drug Delivery Summit

    Hyatt Regency Boston Harbor 101 Harborside Drive, Boston, MA, United States

    The 8th CNS Drug Delivery Summit is the leading industry forum dedicated to overcoming the challenges of delivering therapeutics across the blood-brain barrier and into the central nervous system. Bringing […]

  • World CNS Summit South Korea

    Grand Hyatt Incheon 208 Yeongjonghaeannam-ro, 321 Beon-gil, Yeongjong-gu, 23358, Incheon South Korea

    The World CNS Summit South Korea is the premier industry-focused forum dedicated to advancing targeted, mechanism-differentiated therapies for neurodegenerative, rare neurodevelopmental, and neuropsychiatric disorders. As South Korea emerges as a […]

  • 10th Complement-Based Drug Development Summit

    Hotel Commonwealth 500 Commonwealth Avenue, Boston, MA, United States

    The 10th Complement-Based Drug Development Summit returns at a pivotal moment as the field shifts from validating complement biology to maximizing its clinical and commercial potential. As pipelines expand beyond […]